Pivotal trial of MRI-guided transurethral ultrasound ablation (TULSA) of localized prostate cancer: 4-year follow-up
Pavlovich et al, AUA 2023 Annual Meeting (abstract MP73-05), The Journal of Urology (2023)
Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Cancer
Klotz et al, The Journal of Urology (2021)
Single-center evaluation of treatment success using two different protocols for MRI-guided transurethral ultrasound ablation of localized prostate cancer
Hatiboglu et al, Frontiers in Oncology (2021)
PIVOTAL TRIAL OF MRI-GUIDED TRANSURETHRAL ULTRASOUND ABLATION IN MEN WITH LOCALIZED PROSTATE CANCER: THREE-YEAR FOLLOW-UP
Klotz et al, The Journal of Urology (2021)
MR Imaging-Guided Transurethral Ultrasound Ablation of Localized Prostate Cancer: Preliminary Experience from a Single Center in a Prospective, Multi-Center, Single-Arm Clinical Trial
Sundaram et al, Journal of Vascular and Interventional Radiology (2020)
Confirmation of Safety & Efficacy in Routine Clinical Practice
A retrospective clinical service evaluation of lesion-targeted MRI-guided transurethral ultrasound ablation (TULSA) for the treatment of localized prostate cancer
Muschter et al, AUA 2023 Annual Meeting (abstract MP73-09) ,The Journal of Urology (2023)
MR-guided transurethral ultrasound ablation of prostate cancer: initial experience of monitoring tumor response by dynamic apparent diffusion coefficient measurements at 3.0 T
Meyer et al, Urologia Internationalis (2023)
Initial experience of transurethral ultrasound ablation of the prostate in Asia”, BJUI Compass
Miura et al, BJUI Compass (2022)
Early Single-center Experience with TULSA-PRO (outside of Clinical Trials): Initial United States Experience
Kasraeian et al, WCET 2022 Annual Meeting (abstract MP20-14), Journal of Endourology (2022)
Customized prostate ablation using MRI-guided transurethral ultrasound ablation (TULSA): initial experience at a private radiology practice
Busch et al, SIR 2022 Annual Scientific Meeting (Abstract No. 112), Journal of Vascular and Interventional Radiology (2022)
Single center retrospective analysis of fifty-two prostate cancer patients with customized MR-guided transurethral ultrasound ablation (TULSA)
Lumiani et al, Urologic Oncology (2021)
Durability of Outcomes and Feasibility of Salvage Treatment: Phase I Safety & Precision Study (n=30)
Durability of Functional Outcomes After MRI-Guided Transurethral Ultrasound Ablation of the Prostate
Hatiboglu et al, JU Open Plus (2023)
MRI-guided transurethral ultrasound ablation in patients with localized prostate cancer: Three year outcomes of a prospective Phase I study
Nair et al, BJU International (2020)
Salvage open radical prostatectomy for recurrent prostate cancer following MRI-guided transurethral ultrasound ablation (TULSA) of the prostate: feasibility and efficacy
Nair et al, Scandinavian Journal of Urology (2020)
Twelve-month prostate volume reduction after MRI-guided transurethral ultrasound ablation of the prostate
Bonekamp et al, European Radiology (2018)
CAUTION: Products shown may not be approved for sale in all jurisdictions. Rx only device.
Contact us at info@profoundmedical.com for more information regarding the regulatory status of the device.
106734B